Abstract
Objective
Increased social risk data collection in health care settings presents new opportunities to apply this information to improve patient outcomes. Clinical decision support (CDS) tools can support these applications. We conducted a participatory engagement process to develop electronic health record (EHR)-based CDS tools to facilitate social risk-informed care plan adjustments in community health centers (CHCs).
Materials and Methods
We identified potential care plan adaptations through systematic reviews of hypertension and diabetes clinical guidelines. The results were used to inform an engagement process in which CHC staff and patients provided feedback on potential adjustments identified in the guideline reviews and on tool form and functions that could help CHC teams implement these suggested adjustments for patients with social risks.
Results
Partners universally prioritized tools for social risk screening and documentation. Additional high-priority content included adjusting medication costs and changing follow-up plans based on reported social risks. Most content recommendations reflected partners’ interests in encouraging provider–patient dialogue about care plan adaptations specific to patients’ social needs. Partners recommended CDS tool functions such as alerts and shortcuts to facilitate and efficiently document social risk-informed care plan adjustments.
Discussion and Conclusion
CDS tools were designed to support CHC providers and staff to more consistently tailor care based on information about patients’ social context and thereby enhance patients’ ability to adhere to care plans. While such adjustments occur on an ad hoc basis in many care settings, these are among the first tools designed both to systematize and document these activities.
Keywords: social determinants of health, social risk, health information technology, participatory design, hypertension, diabetes mellitus
INTRODUCTION
Background and significance
Social, economic, environmental, and policy factors that impact health outcomes are called “social determinants of health.” For individual patients, adverse social determinants shape specific social risks, including food, transportation, and housing insecurity.1–5 Given the compelling evidence that social risks influence health, many professional organizations now recommend that social risk screening be integrated into health care delivery.3,6–8 A 2019 National Academies of Sciences, Engineering, and Medicine (NASEM) report on integrating social and medical care describes a framework for the multiple ways social risk data can be used in clinical settings.9 As health care teams increasingly collect information about patients’ social risk(s) (the NASEM framework refers to social risk screening as “awareness” activities) and social risk data become more widely available in electronic health records (EHRs), care teams have more opportunities to use this information to improve patient outcomes, which might reduce related health inequities.9–13 Multiple studies have shown improved clinical outcomes when care plans are “adjusted,”14–18 a term used in the NASEM framework to refer to adapting care plans to account for patients’ reported social risks. However, such “adjustments” are made inconsistently: changes to care based on information about patients’ social conditions are made in <25% of clinical encounters,12,19,20 even when social risk information is shared directly with clinical providers.19–21
Social risk data may be more likely to influence care when accompanied by specific recommendations about how to use them22; providing this type of support to clinical teams may be necessary to ensure that social risk-informed care plan adjustments are made. One potential source of such support is clinical decision support (CDS) tools, which have been shown to facilitate other practice changes by presenting provider-facing reminders about overdue screenings, summarizing a patient’s health risks, and providing guideline-based care recommendations.23–39 To understand how CDS tools might support social risk-informed decision-making at the point of care, we conducted an engagement process that included individuals who may be impacted by or have an interest in these tools (hereinafter referred to as “partners”). The process was designed to inform the development of a suite of EHR-based CDS tools that could help care teams use social risk information to improve care for patients with hypertension and/or type 2 diabetes mellitus (T2DM) in primary care community health centers (CHCs).
MATERIALS AND METHODS
Systematic scoping reviews of clinical guidelines
We conducted systematic scoping reviews of care guidelines from professional organizations on the treatment and management of (1) T2DM and (2) essential hypertension. The guidelines were searched to identify all instances of recommended care plan adaptations based on social context (eg, recommended modification of antihypertensive medication orders based on cost). Detailed methods and findings are described elsewhere.40–42 Review findings were used as the foundation for the partner-driven process described below.
Partner-driven CDS development process
Results from the systematic reviews informed a participatory engagement process43–47 involving staff and patients from CHCs that are members of OCHIN, Inc. OCHIN is a nonprofit health care innovation center that provides a shared instance of Epic EHR to nearly 1000 CHCs across the US.
We developed a committee composed of 12 CHC provider and staff partners recruited to represent diverse geographic regions and primary care clinical roles (including 5 advanced practice providers or physicians, 1 nurse, 1 patient navigator, 1 pharmacist, 1 behavioral health provider, 1 social services manager, 1 quality improvement specialist, and 1 social determinant of health screening program director). Committee members were first given the results of the scoping reviews described above, which consisted of summaries of the adjustments found in the guideline review, organized by key themes and condition. The intent of sharing these guidelines was to help ground the consensus process in the evidence base and guide content-related discussions. We then conducted one-on-one interviews with each committee member to solicit ideas about the CDS tools. Interview guides included short clinical vignettes that were used to encourage committee members to think about clinical care adjustments rather than ways to connect patients with social services (Supplementary Appendix SI). While social services are part of social care, the CDS tools were intended to support functionalities related to adjustments to the clinical care plan. We met with the committee in 5 monthly sessions to solicit input on the ideas generated both from the scoping review and interviews. Committee members were asked to focus on tool content (topics), functions (eg, alerts, reminders of overdue screenings), and form (appearance and placement in the EHR) of recommended CDS tools.
All interviews and committee meetings took place via video teleconferencing. Both were audio recorded. Interviews were professionally transcribed verbatim; detailed notes were taken during each meeting and audio recorded as a secondary measure to capture the feedback. To facilitate participation in the meetings, real-time polling, teleconference chat functions, invitations to provide additional feedback, tool and workflow mock-ups, and ad hoc surveys were used during and after each meeting. Survey questions, administered via an online survey platform, were designed both to elicit further feedback on items discussed in the meetings and to assess majority opinion about preferences.
The topical focus of each of the 5 meetings is presented in Figure 1. In brief, over the first 3 meetings committee members were presented with potential CDS content options suggested either by the scoping reviews or partner interviews, and asked to review, provide feedback, and prioritize these proposed content elements. At subsequent meetings, the committee was asked to comment on the function and form of the tools initially developed to reflect content preferences. The CDS functions continued to be revised based on prior input and re-presented to the partners for additional feedback over the course of the meeting series.
Figure 1.
Timeline of activities.
Throughout this process, the multidisciplinary research team met regularly to discuss and interpret all input by rapidly analyzing committee meeting notes and reviewing the technical feasibility of building specific tool functions in the EHR. Over the course of the 5 committee meetings, these interpretations were shared for member checking, and the committee proposed additional tool changes to accommodate feasibility barriers. The interviews were exploratory in nature and served to stimulate discussion and expand understanding of the factors and interactions to consider when developing the CDS tools. Transcripts were analyzed by the study’s qualitative team using a rapid analytic approach and a findings summary informed content and form discussions in the committee meetings.
We presented the proposed suite of tools to OCHIN’s Patient Engagement Panel, an established group of CHC patients and caregivers from across the US who meet regularly to provide input on research-related EHR changes, some of whom may experience social risks or manage chronic conditions described in this study.48 Patients and caregivers were asked for feedback on when and how they would like providers to discuss care adjustments based on their socioeconomic circumstances. We also solicited specific feedback on the proposed patient-facing language shown in EHR tools designed to serve as conversation prompts, and in the patient’s after-visit summary (AVS). The proposed tools were also presented to OCHIN’s Clinical Operations Review Committee, comprised of clinical leaders from across OCHIN’s CHCs who provide input on all proposed EHR changes.49,50 The Kaiser Permanente Northwest Institutional Review Board reviewed this study, which was determined to be exempt from IRB oversight.
RESULTS
Tool content
Nineteen content recommendations were initially presented to the committee based on scoping reviews or one-on-one interviews. Table 1 represents all considered adjustments, the intended purpose of each adjustment, and the partners’ suggestions about whether to include related content in the suite of CDS tools. The adjustments are organized into categories aligned with common clinical activities.
Table 1.
Original list of adjustments
| Adjustment-related category | Intended purpose of adjustment | Adjustment accepted for development |
|---|---|---|
| Increase social risk awareness, screening, and documentation | ||
| Screen patient for social risk | Increase documentation of social risks | Yes |
| Document social risk in patient record (Z-codes) | Increase care team awareness of social risks | Yes |
| Medical red flags may indicate need for adjusting care plan | Identify patients whose social risks may be impacting health | Yes |
| Facilitate patient–provider discussions about social risks and document discussions | ||
| Collaborate with patient on their social risk-informed care plan | Improve patient’s chance of care plan follow-through | Yes |
| Ensure patient instructions are at appropriate literacy level and language | Increase accessibility for all patients | Yes |
| Recommend care changes and document changes | ||
| Prescriptions | ||
| Document patient barriers to taking medications | Increase care team’s awareness of all care activities and patient’s social barriers | Yes |
| Prescribe less expensive medications, such as generic meds, when feasible | Lower cost of patient’s medications | Yes |
| Provide patient with an option to have their medication delivered to home | Minimize patient trips to pharmacy | Yes |
| Prescribe long acting or combination medications | Lower cost of patient’s medication; simplify medication regimen | No; Building medication algorithm too complex for scope |
| Prescribe a larger-than-needed dose of medication and recommend usage of a pill splitter | Lower cost of patient’s medication | No; Insurance coverage challenges, concern re: patient safety issues |
| Recommend the usage of a weekly pill organizer | Simplify patient’s medication regimen | No; Implementation logistics considered too burdensome for clinics; perception of limited value |
| Prescribe a 90-day dose of medication | Simplify patient’s medication regimen; minimize patient trips to pharmacy; lower patient medication costs | Yes |
| Utilize GoodRx.com to find lowest cost medications, particularly if patient is designated as self-pay | Lower cost of patient’s medication | Yes |
| Conversation with patient about titrating insulin; consider risk of hypoglycemia | Ensure medication safety if patient experiences food insecurity | Yes |
| Communicate with pharmacists about lowering medication costs | Lower cost of patient’s medication | Yes |
| Follow-up care | ||
| Provide patient with an option of follow-up care via telemedicine | Minimize patient trips to clinic | Yes |
| Limit the overall number and frequency of clinic visits | Minimize patient trips to clinic | Yes |
| Refer to clinic-based CHW or social worker | Improve coordinated care team support | Yes |
| Provide patient with a home monitoring device | Minimize patient trips to clinic | No; Insurance coverage challenges |
The committee suggested 15/19 recommendations would be feasible to implement. Reasons that 4 adjustments were not considered feasible are described in Table 1. Of these 15, partners universally prioritized tool content specific to social risk screening and documentation. Additional high-priority content related to adjusting medication costs and changing follow-up visit plans were developed based on reported social risks. The majority of other high-priority content recommendations reflected partners’ interest in encouraging more dialogue between providers and patients about care plan accommodations specific to patients’ reported social needs. Priorities varied regarding the specificity of tool content. State and payer laws influenced priorities (eg, partners in states allowing 90-day prescriptions wanted 90-day prescription defaults), as did local context (eg, CHCs with onsite pharmacies providing federally discounted prescription medications were less interested in referrals to pharmacies providing medication delivery services). Tool content dependent on state, payer, or local context, therefore, was designed as elective (ie, CHCs could opt into it) to accommodate regional and clinic-specific needs. The flexibility to customize the tools to local context was of high importance to the partners.
CDS tools: form and function
As consensus developed regarding the content for the CDS tools, the partners considered specific form and functions for presenting this content in the EHR. These included determining when in the primary care visit workflow the CDS tools would appear (eg, rooming, encounter documentation, follow-up); the logic triggering their appearance (eg, for patients with T2DM being prescribed a new medication vs all patients with T2DM); where they would appear (eg, multiple locations in the EHR vs only at point of prescribing); and the degree of customization needed (eg, prescribing 90-day supply depending on state and payer laws).
Tool form
Based on the results of these discussions, the CDS tools were built primarily into SmartSets and Best Practice Advisories, which are commonly used EHR tools (see Supplementary Appendix SII for examples). Most of the related adjustment recommendations are suggested in both formats. SmartSets provide a standardized way to place orders, document diagnoses, and write progress notes for patients with a given medical condition. A range of adjustment recommendations was embedded within SmartSets. Each appears as a selectable option and means care can be adjusted with one mouse click. The social risk-informed care recommendations were incorporated into 4 SmartSets; 3 were inserted into existing EHR SmartSets (Hypertension, Diabetes, Care Gaps) and one was developed specifically for this study (Social Needs and Care Planning). Since not all providers regularly use SmartSets for charting, however, Best Practice Advisories—which provide a visual reminder intended to guide clinical decision-making and care provision—offered an alternative way for these providers to view the same CDS suggestions. Best Practice Advisories are in the “Rooming” and “Plan” sections of the EHR where rooming staff and providers document most encounter-related content. Interruptive popup Best Practice Advisories following social risk screening entry target users completing each part of the encounter workflow. Relevant medication-related suggestions are also embedded within Best Practice Advisories that appear when ordering prescriptions. Several committee members expressed concerns that the CDS tools could negatively interrupt clinic workflow, particularly providers for whom may see the CDS tools most frequently and emphasized the need to minimize the need for clicks or hard stops.
Tool function
A summary of the content in the suite of CDS tools is shown in Table 2 and described in detail below. The tools appear to CHC staff based on patients’ clinical and social risk information. First, the CDS tools identify patients with a medical “red flag,” a term that other researchers define as a clinical cue that something might be interfering with the patient’s ability to follow the care plan.15 In this study, red flags are defined as uncontrolled hypertension (BP ≥ 140/90), uncontrolled T2DM (HgA1c ≥ 9.0), or in patients with either hypertension or T2DM, an appointment no-show rate of >50% of visits in the last year, all of which would have been identified in prior visits and already in the patient record. Table 2 presents a summary of the final CDS tools developed based on the committee’s input, organized into categories aligned with common clinical activities (screening, patient–provider discussions, and care planning/follow-up).
Table 2.
Summary of CDS tools
| Adjustment-related category | Adjustment tools | Documentation tools |
|---|---|---|
| Increase social risk screening and documentation | ||
|
|
|
| Facilitate patient–provider discussions about social risks and document discussions | ||
|
|
|
| Recommend care changes and document changes | ||
| Prescriptions | ||
|
|
|
| Follow-up care | ||
|
|
|
AVS: after-visit summary; BP: blood pressure; CDS: clinical decision support; CHW: community health worker; HgA1c: hemoglobin A1C; T2DM: type 2 diabetes mellitus.
Optional.
Tools to increase screening and documentation of social risks
Certain adjustment and documentation tools are designed specifically to support providers’ awareness and documentation of social risks. These were built into the EHR’s best practice section for rooming staff. If a patient has a red flag and if the last recorded financial-related social risk screening occurred >12 months ago, an alert prompts rooming staff to screen for social risks, with a link to the screening form. If a patient has a documented social risk (eg, financial insecurity) when the user saves the form, an interruptive alert appears offering to add the relevant ICD-10 Z-code(s) to the patient’s problem list with one click. Adding social risk-related Z-codes to the problem list enables health care team members to systemically document ongoing issues experienced by the patient and can be important to CHCs’ quality reporting and reimbursement. The rooming staff is required to accept or cancel the Best Practice Advisory before continuing. If the user accepts the suggested Z-codes, they are added to the problem list, and those Best Practice Advisories are not shown to the provider as the suggested documentation is now complete. If the Best Practice Advisories are canceled, they will appear passively when the provider opens the patient’s chart.
At each visit, rooming staff in most CHCs are asked to document medication adherence for all prescriptions. Medication adherence documentation was already in the EHR; a new Best Practice Advisory appears recommending that staff conduct this assessment. When documenting, rooming staff can indicate if the patient is taking a given medication differently than prescribed or not at all due to cost. Medication variance shows in the Medication & Orders section of the chart, where this information is highlighted for provider review.
Tools to facilitate and document patient–provider discussions about social risks
Both the Best Practice Advisory and SmartSet presentations of the tools include conversation prompts, which reflect suggested topics and scripts to enable patient–provider conversations about potential care plan adjustments. The SmartSet tools also include selectable actions that enable providers to document notes, orders, diagnoses, or patient instructions taken in response to the prompt. The conversation prompts include recommendations that providers discuss, for example, (1) whether social needs might influence patients’ ability to act on the care plan/take medication as prescribed; (2) strategies for lowering medication costs/improve medication access by using generic medications or suggesting GoodRx,51 a free website that provides discounts on medications; (3) considerations related to follow-up visit modality (eg, in-person vs telehealth follow-up); and (4) when relevant, risks associated with using insulin in the context of food insecurity. In the SmartSets, each conversation prompt is accompanied by an option for the provider to add text to the progress note and/or patient instructions regarding adjustments. Table 3 shows examples of conversation prompts with both the associated progress note text and patient AVS instruction text. Notably, patient–facing communication was reviewed by the study’s Epic trainer to ensure a 4th grade reading level.
Table 3.
CDS conversation prompts
| Adjustment tool | Conversation prompt in Best Practice Advisory/SmartSet | Templated progress note texta | Templated AVS texta |
|---|---|---|---|
| Titrating insulin dose in patient with financial insecurity/food insecurity | “Discuss the risk of hypoglycemia and need to titrate insulin based on food availability.” | “Discussed with the patient how to titrate insulin dose based on food availability.” | “Access to safe and nutritious food should influence insulin dosing. You and your provider discussed when and how to adjust your insulin dose based on the availability of safe and nutritious food.” |
| Medication adherence for patients with new prescription for T2DM or hypertension | “Many patients have additional barriers. Consider asking the patient if anything will keep [patient’s preferred pronoun] from taking medications as prescribed.” | “We discussed whether the patient’s social need(s) might prevent them from acting on the care plan (Free text: describe medication-related care adjustments).” | Medication-related care adjustments included in AVS. |
| Prompt discussion about visit follow-up (eg, telehealth vs in person and scheduling interval) | “Consider telehealth AND/OR longer interval before the follow-up appointment. Ask the patient if a telehealth follow-up appointment is feasible and preferable to an in-person follow-up appointment. If so, confirm Internet access and required technology. Consider patient preferences and barriers when choosing follow-up appointment intervals.” | “Based on social risks, we discussed patient’s preferences for follow-up timeframe and modality.” | Follow-up appointment date and modality included in AVS. |
| Prompt discussion about interest in medication home delivery | “Tell the patient that the pharmacist may be able to make recommendations to lower medication costs.” | “Suggested the patient talk with the pharmacist about ways to lower medication costs and home delivery.” | “Ask your pharmacist about whether there are similar lower-cost medications and/or about whether your medications can be mailed to where you live.” |
| Suggest use of GoodRx | “Patient may have insufficient medication coverage. The cost of medications may be a barrier. Consider suggesting GoodRx.” | “Discussed medication cost and GoodRx with the patient.” | “Consider using the discount pharmacy codes from GoodRx when purchasing your prescription to help lower your medication costs. You can apply these discounts at most major pharmacies.” |
AVS: after-visit summary; T2DM: type 2 diabetes mellitus.
Modifiable by provider.
Tools to recommend and document care changes—Prescribing tools
When prescribing medications to patients with social needs, a Best Practice Advisory targeted to the patients’ social needs/medication order will appear. As relevant, the Best Practice Advisory alerts the user that a given medication is not available as generic, to consider a 90-day prescription, and to send a note to the pharmacist to discuss options for lowering medication costs or home delivery of medications. Providers have an opportunity to edit this text before signing the order.
Tools to recommend and document care changes—Follow-up care tools
The SmartSet version of the tools also enables providers to add preferred follow-up appointment modalities, such as scheduling telehealth appointments for patients who experience transportation barriers.
DISCUSSION
Through a participatory engagement process, we designed a suite of CDS tools intended to help primary care teams document and apply information about patients’ social risks as part of hypertension and T2DM care. The tools’ content originated from T2DM and hypertension care guidelines and from CHC staff and patients and was reviewed by partners for anticipated usefulness and feasibility in practice. The tools are intended to support care teams to identify and document social risks, prompt providers to discuss potential care changes based on those risks with their patients, and then to document any care changes that are made.
In other contexts, CDS tools have been shown to improve patient outcomes and cost of care,23,52–54 but to our knowledge they have not yet been designed specifically to enhance clinical decision-making by providing relevant information about patients’ social context and/or to recommend strategies to decrease the influence of social adversity on care plan adherence. Ideally, these new tools could support patients and providers to work together to adjust care in ways that will maximize care adherence and subsequently both improve outcomes and decrease inequities. Though this study focused on clinical care adjustments, other initiatives that use social risk information to inform referrals to government and community-based resources are needed; these also should be developed to meet the needs and priorities of different partners.
In fall 2021, a 1-year pilot of this suite of CDS tools began in 3 CHCs. During and after the pilot, tool users will be asked to provide recommendations on needed tool content, form, and usability revisions. Committee members in the development phase suggested that we also monitor pilot CHCs for alert fatigue and ask specifically about the relevance of each tool component in different regions. Based on pilot findings, tools and associated training materials subsequently will be modified to address all learnings from this process in preparation for formal testing in a subsequent clinical trial; the protocol for this trial is described elsewhere.41
Limitations
Tool development should be reviewed in light of several study limitations. First the clinical partners on the committee that provided input on the tools’ content, form, and function were intentionally recruited to reflect regional and staff member diversity within CHCs. Nonetheless, a different group of partners might have led us to develop a different suite of tools. Another challenge was that the suggestions for social risk-related care adjustments included in professional disease management and treatment guidelines often differed from our partners’ priorities. In the final suite of tools, we limited content abstracted from the professional guidelines to topics on which the majority of partners agreed. As both professional guidelines and EHRs evolve, it may be worthwhile to repeat this kind of review and partner engagement process to elicit new ideas about meaningfully incorporating social risk information to improve care and again assess the feasibility of incorporating these suggestions into tool updates. In addition, this work focuses on the development of EHR-based CDS tools for T2DM and hypertension management; future research would be warranted to adapt such tools to support caring for patients with social risks and other chronic conditions. Finally, several partners noted that potential provider burdens of CDS. Though we developed tools to minimize time and efficiency burdens, future research will need to focus on the extent of this burden and weigh tool benefits against costs.
CONCLUSION
We used partner input to develop a suite of CDS tools intended to support clinical providers to tailor care decisions based on patients’ social circumstances. While such care plan adjustments currently occur on an ad hoc basis in many care settings serving vulnerable patients, these are among the first EHR-based tools designed to systematize and document social care adjustments.
HUMAN INVESTIGATIONS
The Institutional Review Board at Kaiser Permanente Northwest reviewed this study and determined it exempt from IRB oversite.
PRIOR PRESENTATIONS
Results of this study were presented on November 22, 2021, at the virtual 49th North American Primary Care Research Group Annual Meeting and on December 12, 2022, at the 15th Annual Conference on the Science of Dissemination and Implementation in Health Conference in Washington, DC.
TRIAL REGISTRATION
Clinical Trials registration title: COHERE—COntextualized care in cHcs’ Electronic health Records NCT05022316 registered August 25, 2021.
Supplementary Material
ACKNOWLEDGMENTS
The authors appreciate the expertise of this study’s committee members and of the participating individuals from OCHIN’s Clinical Operations Review Committee and the Patient Engagement Panel. They would also like to thank Shelby Watkins and Summer Rivera for their support in preparing this manuscript.
Contributor Information
Rose Gunn, OCHIN, Inc., Portland, Oregon, USA.
Maura Pisciotta, OCHIN, Inc., Portland, Oregon, USA.
Rachel Gold, OCHIN, Inc., Portland, Oregon, USA; Kaiser Permanente Center for Health Research, Kaiser Permanente, Portland, Oregon, USA.
Arwen Bunce, OCHIN, Inc., Portland, Oregon, USA.
Katie Dambrun, OCHIN, Inc., Portland, Oregon, USA.
Erika K Cottrell, OCHIN, Inc., Portland, Oregon, USA; Department of Medical Informatics & Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon, USA.
Danielle Hessler, Department of Family and Community Medicine, University of California San Francisco, San Francisco, California, USA.
Mary Middendorf, OCHIN, Inc., Portland, Oregon, USA.
Miguel Alvarez, OCHIN, Inc., Portland, Oregon, USA.
Lydia Giles, Wallace Medical Concern, Portland, Oregon, USA.
Laura M Gottlieb, Department of Family and Community Medicine, University of California San Francisco, San Francisco, California, USA.
FUNDING
This work was supported by the National Institute on Minority Health and Health Disparities award number R01MD014886. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funder.
AUTHOR CONTRIBUTIONS
LG, RG, AB, EC, and DH created the study design. AB and KD conducted interviews. All authors contributed equally to the conception of the manuscript; the analysis and interpretation of data; the drafting and revision of the manuscript and the final approval of the version to be published and are accountable for all aspects of the work.
SUPPLEMENTARY MATERIAL
Supplementary material is available at Journal of the American Medical Informatics Association online.
CONFLICT OF INTEREST STATEMENT
The authors have no competing interests to declare.
DATA AVAILABILITY
The data underlying this article will be shared on reasonable request to the corresponding author.
REFERENCES
- 1. World Health Organization. Social Determinants of Health. https://www.who.int/teams/social-determinants-of-health. Accessed November 29, 2020.
- 2. Office of Disease Prevention and Health Promotion. Healthy People. https://www.healthypeople.gov/2020/topics-objectives. Accessed February 15, 2019.
- 3. Institute of Medicine: Board on Population Health and Public Health Practice: Committee on the Recommended Social and Behavioral Domains and Measures for Electronic Health Records. In: Capturing Social and Behavioral Domains in Electronic Health Records: Phase 1. Washington (DC: ): National Academies Press; 2014. [PubMed] [Google Scholar]
- 4. Alderwick H, Gottlieb LM.. Meanings and misunderstandings: a social determinants of health lexicon for health care systems. Milbank Q 2019; 97 (2): 407–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Peek CJ, Westfall JM, Stange KC, et al. Shared language for shared work in population health. Ann Fam Med 2021; 19 (5): 450–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. American Academy of Pediatrics Council on Community Pediatrics. Poverty and child health in the United States. Pediatrics 2016; 137 (4): e20160339. [DOI] [PubMed] [Google Scholar]
- 7. American Academy of Family Physicians. Social Determinants of Health Policy. 2019. https://www.aafp.org/about/policies/all/social-determinants.html. Accessed February 13, 2019.
- 8. Daniel H, Bornstein SS, Kane GC, et al. ; Health and Public Policy Committee of the American College of Physicians. Addressing social determinants to improve patient care and promote health equity: an American College of Physicians position paper. Ann Intern Med 2018; 168 (8): 577–8. [DOI] [PubMed] [Google Scholar]
- 9. National Academies of Sciences Engineering, and Medicine. Integrating social Care into the Delivery of Health Care: Moving Upstream to Improve the Nation's Health. Washington (DC: ): National Academies Press; 2019. [PubMed] [Google Scholar]
- 10. Davidson KW, Krist AH, Tseng CW, et al. Incorporation of social risk in US Preventive Services Task Force recommendations and identification of key challenges for primary care. JAMA 2021; 326 (14): 1410–5. [DOI] [PubMed] [Google Scholar]
- 11. DeVoe JE, Bazemore AW, Cottrell EK, et al. Perspectives in primary care: a conceptual framework and path for integrating social determinants of health into primary care practice. Ann Fam Med 2016; 14 (2): 104–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Hessler D, Bowyer V, Gold R, Shields-Zeeman L, Cottrell E, Gottlieb LM.. Bringing social context into diabetes care: intervening on social risks versus providing contextualized care. Curr Diab Rep 2019; 19 (6): 30. [DOI] [PubMed] [Google Scholar]
- 13. Knighton AJ, Stephenson B, Savitz LA.. Measuring the effect of social determinants on patient outcomes: a systematic literature review. J Health Care Poor Underserved 2018; 29 (1): 81–106. [DOI] [PubMed] [Google Scholar]
- 14. Weiner S, Schwartz A, Altman L, et al. Evaluation of a patient-collected audio audit and feedback quality improvement program on clinician attention to patient life context and health care costs in the Veterans Affairs Health Care System. JAMA Netw Open 2020; 3 (7): e209644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Weiner SJ, Schwartz A.. Contextual errors in medical decision making: overlooked and understudied. Acad Med 2016; 91 (5): 657–62. [DOI] [PubMed] [Google Scholar]
- 16. Weiner S, Schwartz A.. Listening for What Matters: Avoiding Contextual Errors in Health Care. New York, NY: Oxford University Press; 2015. [Google Scholar]
- 17. Senteio C, Adler-Milstein J, Richardson C, Veinot T.. Psychosocial information use for clinical decisions in diabetes care. J Am Med Inform Assoc 2019; 26 (8–9): 813–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Weiner SJ, Schwartz A, Sharma G, et al. Patient-centered decision making and health care outcomes: an observational study. Ann Intern Med 2013; 158 (8): 573–9. [DOI] [PubMed] [Google Scholar]
- 19. Weiner SJ, Schwartz A, Weaver F, et al. Contextual errors and failures in individualizing patient care: a multicenter study. Ann Intern Med 2010; 153 (2): 69–75. [DOI] [PubMed] [Google Scholar]
- 20. Tong ST, Liaw WR, Kashiri PL, et al. Clinician experiences with screening for social needs in primary care. J Am Board Fam Med 2018; 31 (3): 351–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Levinson W, Gorawara-Bhat R, Lamb J.. A study of patient clues and physician responses in primary care and surgical settings. JAMA 2000; 284 (8): 1021–7. [DOI] [PubMed] [Google Scholar]
- 22. Solberg LI. Theory vs practice: should primary care practice take on social determinants of health now? No. Ann Fam Med 2016; 14 (2): 102–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Tcheng JE, Bakken S, Bates DW, Bonner H III, Gandhi TK, Josephs M, Kawamoto K, Lomotan EA, Mackay E, Middleton B, Teich JM, Weingarten S, Hamilton Lopez M, eds. Optimizing Strategies for Clinical Decision Support: Summary of a Meeting Series. Washington, DC: National Academy of Medicine; 2017. [PubMed] [Google Scholar]
- 24. O'Connor PJ, Sperl-Hillen JM, Rush WA, et al. Impact of electronic health record clinical decision support on diabetes care: a randomized trial. Ann Fam Med 2011; 9 (1): 12–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Dudl RJ, Wang MC, Wong M, Bellows J.. Preventing myocardial infarction and stroke with a simplified bundle of cardioprotective medications. Am J Manag Care 2009; 15 (10): e88–94. [PubMed] [Google Scholar]
- 26. Gilmer TP, O'Connor PJ, Sperl-Hillen JM, et al. Cost-effectiveness of an electronic medical record based clinical decision support system. Health Serv Res 2012; 47 (6): 2137–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Ash JS, Sittig DF, Guappone KP, et al. Recommended practices for computerized clinical decision support and knowledge management in community settings: a qualitative study. BMC Med Inform Decis Mak 2012; 12: 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Ash JS, Sittig DF, Dykstra R, et al. Identifying best practices for clinical decision support and knowledge management in the field. Stud Health Technol Inform 2010; 160 (Pt 2): 806–10. [PMC free article] [PubMed] [Google Scholar]
- 29. Bright TJ, Wong A, Dhurjati R, et al. Effect of clinical decision-support systems: a systematic review. Ann Intern Med 2012; 157 (1): 29–43. [DOI] [PubMed] [Google Scholar]
- 30. Kawamoto K, Houlihan CA, Balas EA, Lobach DF.. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ 2005; 330 (7494): 765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Lobach D, Sanders GD, Bright TJ, et al. Enabling health care decisionmaking through clinical decision support and knowledge management. Evid Rep Technol Assess (Full Rep) 2012; (203): 1–784. [PMC free article] [PubMed] [Google Scholar]
- 32. Souza NM, Sebaldt RJ, Mackay JA, et al. ; the CCDSS Systematic Review Team. Computerized clinical decision support systems for primary preventive care: a decision-maker-researcher partnership systematic review of effects on process of care and patient outcomes. Implement Sci 2011; 6 (1): 87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Roshanov PS, You JJ, Dhaliwal J, et al. ; CCDSS Systematic Review Team. Can computerized clinical decision support systems improve practitioners' diagnostic test ordering behavior? A decision-maker-researcher partnership systematic review. Implement Science 2011; 6: 88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Jaspers MW, Smeulers M, Vermeulen H, Peute LW.. Effects of clinical decision-support systems on practitioner performance and patient outcomes: a synthesis of high-quality systematic review findings. J Am Med Inform Assoc 2011; 18 (3): 327–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Moja L, Kwag KH, Lytras T, et al. Effectiveness of computerized decision support systems linked to electronic health records: a systematic review and meta-analysis. Am J Public Health 2014; 104 (12): e12–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Murphy EV. Clinical decision support: effectiveness in improving quality processes and clinical outcomes and factors that may influence success. Yale J Biol Med 2014; 87 (2): 187–97. [PMC free article] [PubMed] [Google Scholar]
- 37. Goud R, de Keizer NF, ter Riet G, et al. Effect of guideline based computerised decision support on decision making of multidisciplinary teams: cluster randomised trial in cardiac rehabilitation. BMJ 2009; 338: b1440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. López L, Green AR, Tan-McGrory A, King R, Betancourt JR.. Bridging the digital divide in health care: the role of health information technology in addressing racial and ethnic disparities. Jt Comm J Qual Patient Saf 2011; 37 (10): 437–45. [DOI] [PubMed] [Google Scholar]
- 39. The Office of the National Coordinator for Health Information Technology (ONC). Health IT Enabled Quality Improvement: A Vision to Achieve Better Health and Health Care. 2014. https://www.healthit.gov/sites/default/files/HITEnabledQualityImprovement-111214.pdf. Accessed February 2, 2019.
- 40. Razon N, Hessler D, Bibbins-Domingo K, Gottlieb L.. How hypertension guidelines address social determinants of health: a systematic scoping review. Med Care 2021; 59 (12): 1122–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Gold R, Sheppler C, Hessler D, et al. Using electronic health record-based clinical decision support to provide social risk-informed care in community health centers: protocol for the design and assessment of a clinical decision support tool. JMIR Res Protoc 2021; 10 (10): e31733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Aceves B, Gunn R, Pisciotta M, et al. Social care recommendations in National Diabetes Treatment Guidelines. Curr Diab Rep 2022; 22 (10): 481–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Ozkaynak M, Sircar CM, Frye O, Valdez RS.. A systematic review of design workshops for health information technologies. Informatics 2021; 8 (2): 34. [Google Scholar]
- 44. Novak L, Harris J.. Anthropology and Informatics in Health Care. Oxford: Oxford University Press; 2020. [Google Scholar]
- 45. Vandekerckhove P, de Mul M, Bramer WM, de Bont AA.. Generative participatory design methodology to develop electronic health interventions: systematic literature review. J Med Internet Res 2020; 22 (4): e13780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Smith RC, Bossen C, Kanstrup AM.. Participatory design in an era of participation. CoDesign 2017; 13 (2): 65–9. [Google Scholar]
- 47. Smith RC, Bossen C, Kanstrup AM. Participatory design in an era of participation. CoDesign 2017; 13 (2): 65–9.
- 48. Arkind J, Likumahuwa-Ackman S, Warren N, et al. Lessons learned from developing a patient engagement panel: an OCHIN report. J Am Board Fam Med 2015; 28 (5): 632–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. LaForge K, Gold R, Cottrell E, et al. How 6 organizations developed tools and processes for social determinants of health screening in primary care: an overview. J Ambul Care Manage 2018; 41 (1): 2–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Gold R, Cottrell E, Bunce A, et al. Developing electronic health record (EHR) strategies related to health center patients' social determinants of health. J Am Board Fam Med 2017; 30 (4): 428–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. GoodRx. Stop Paying Too Much For Your Prescriptions. 2022. https://www.goodrx.com/. Accessed May 12, 2022.
- 52. Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI.. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med 2020; 3 (1): 17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Teich JM, Osheroff JA, Pifer EA, Sittig DF, Jenders RA, Panel TCER.. Clinical decision support in electronic prescribing: recommendations and an action plan: report of the Joint Clinical Decision Support Workgroup. J Am Med Inform Assoc 2005; 12 (4): 365–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Kwan JL, Lo L, Ferguson J, et al. Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ 2020; 370: m3216. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data underlying this article will be shared on reasonable request to the corresponding author.

